Figure 1
From: Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
Plasma D-dimer levels are expressed as the median and 5%-95% percentile in patients with nasopharyngeal carcinoma according to different variables. (A) Healthy volunteers versus nasopharyngeal carcinoma patients; (B) Nasopharyngeal carcinoma with distant metastasis after treatment versus non-distant metastasis (P = 0.002); (C) Non-survivors versus survivors (P = 0.002); (D) High DNA (≥4000 copies/ml) versus low DNA (<4000 copies/ml) (P = 0.002).